Cargando…
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
Synaptic abnormalities are a cardinal feature of Alzheimer’s disease (AD) that are known to arise as the disease progresses. A growing body of evidence suggests that pathological alterations to neuronal circuits and synapses may provide a mechanistic link between amyloid β (Aβ) and tau pathology and...
Autores principales: | Gao, Lina, Zhang, Yun, Sterling, Keenan, Song, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796548/ https://www.ncbi.nlm.nih.gov/pubmed/35090576 http://dx.doi.org/10.1186/s40035-022-00279-0 |
Ejemplares similares
-
Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through the Modulation of Brain-Derived Neurotrophic Factor
por: Nelson, Mackayla L., et al.
Publicado: (2023) -
Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
por: Zhang, Yun, et al.
Publicado: (2023) -
Association of plasma brain-derived neurotrophic factor with Alzheimer’s disease and its influencing factors in Chinese elderly population
por: Qian, Fuqiang, et al.
Publicado: (2022) -
Brain-derived neurotrophic factor interplay with oxidative stress: neuropathology approach in potential biomarker of Alzheimer’s disease
por: Shen, Robert, et al.
Publicado: (2023) -
Brain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities
por: Liu, Wei, et al.
Publicado: (2020)